The patient was discharged free of symptoms two weeks prior to pr

The patient was discharged free of symptoms two weeks prior to presentation in our department. Following admission to our emergency room, an immediate Selleckchem Linsitinib CT-scan and a blood test were performed, as the patient showed signs of an initiating peritonitis. The CT scan showed an isolated re-dissection in the proximal part of the SMA with

embolization of a distal branch causing an almost complete decline of right hand side intestinal Pevonedistat perfusion. Aggravating, the right hepatic artery originated from the proximal part of the SMA as an anatomical variant. The origin was located directly in the region of the dissection entry. Figure 1 shows the major findings of the CT scan on admission. As endovascular therapy had a high risk of post interventional liver failure, the decision for open surgery was taken at an interdisciplinary level. Blood test PD0332991 supplier results showed a normal serum lactate level, while C-reactive protein (CRP) and leukocytes (WBC) were raised. Thus, the patient had to be transferred urgently to the operating theatre. We resected the dissection membrane from the origin of the SMA and a selective embolectomy of the arcade arteries was performed. The SMA was

re-constructed using a venous interponate. Thus, for the interposition the saphenous vein from the right upper leg was used. The patient was admitted to the intensive care unit (ICU) with an abdomen apertum. As hypercoagulability occurred during the operation and we suspected a heparin induced

thrombopenia (HIT), anticoagulation was managed using Argatroban with an activated partial thromboplastin time (aPTT) of 50-70 seconds. This suspicion was later confirmed due to a Heparin-induced Thrombocytopenia Platelet Factor 4 Antibody Test. Figure 1 demonstrates the representative findings of a CT-scan control five days after the operation. As a further course, negative wound pressure therapy was performed with wound dressing changes at intervals of two days and conducted within in the operating theatre (four times). In this context, the small intestinum was carefully inspected. We could not find any signs of hypoperfusion lesions. As the patient described persistent abdominal pain, performing a colonoscopy six Methocarbamol days after the operation meant that ischemic colitis could be ruled out. Figure 1 Representative CT scan findings. A: shown is the entry of the dissection at the proximal SMA. An abnormal origin of the right hepatic artery from the proximal SMA can be seen as an anatomical variant. B: An embolism of a distal branch of the SMA is shown. C: Reconstruction of the CT scan after admission. Almost complete decline of intestinal perfusion of the right abdominal side could be observed. D: findings of the control CT scan 5 days after operation. No residual membrane could be observed, normal perfusion of the SMA and the right hepatic artery.

The advisors assisted in developing the study protocol and the st

The advisors assisted in developing the study SRT1720 clinical trial protocol and the statistical analysis plan, made recommendations on the analysis selleck compound library and

exploitation of the study results and contributed to the writing of the present article. Both received honoraria from the sponsor in return for their participation. Data analysis was performed by Stat-Process, an independent data analysis company working in the field of healthcare, which was responsible for the extraction of the source data from the Thalès database, contributed to the statistical analysis plan and produced the statistical report. Stat-Process received fees from Laboratoire GlaxoSmithKline for its involvement in the study. Laboratoire GlaxoSmithKline also funded the editorial support for the preparation of the present article. The authors thanks Adam Doble (Foxymed, Paris, France) for help in preparing the manuscript. Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original

author(s) and source are credited. Conflicts of interest C. Roux has received research grants and/or speaker’s fees from Alliance, Amgen, Lilly, MSD, Novartis, GSK-Roche, Servier and Wyeth. References 1. World Health Organization (2003) Adherence to Tipifarnib long-term therapies: evidence for action. World C-X-C chemokine receptor type 7 (CXCR-7) Health Organization, Geneva, Switzerland 2. Vik SA, Hogan DB, Patten SB, Johnson JA, Romonko-Slack L, Maxwell CJ (2006) Medication nonadherence and subsequent risk of hospitalisation and mortality among older adults. Drugs Aging 23:345–356CrossRefPubMed 3. Cramer JA, Gold DT, Silverman SL, Lewiecki EM (2007) A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 18:1023–1031CrossRefPubMed 4. Lekkerkerker F, Kanis JA, Alsayed

N, Bouvenot G, Burlet N, Cahall D, Chines A, Delmas P, Dreiser RL, Ethgen D, Hughes N, Kaufman JM, Korte S, Kreutz G, Laslop A, Mitlak B, Rabenda V, Rizzoli R, Santora A, Schimmer R, Tsouderos Y, Viethel P, Reginster JY (2007) Adherence to treatment of osteoporosis: a need for study. Osteoporos Int 18:1311–1317CrossRefPubMed 5. Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK (2008) Medication compliance and persistence: terminology and definitions. Value Health 11:44–47PubMed 6. Geusens PP, Roux CH, Reid DM, Lems WF, Adami S, Adachi JD, Sambrook PN, Saag KG, Lane NE, Hochberg MC (2008) Drug insight: choosing a drug treatment strategy for women with osteoporosis—an evidence-based clinical perspective. Nat Clin Pract Rheumatol 4:240–248CrossRefPubMed 7. Tosteson AN, Grove MR, Hammond CS, Moncur MM, Ray GT, Hebert GM, Pressman AR, Ettinger B (2003) Early discontinuation of treatment for osteoporosis. Am J Med 115:209–216CrossRefPubMed 8.

L asiaticus’, it should be noted that broader population analyse

L. asiaticus’, it should be noted that broader population analyses using a larger array of molecular markers will help resolved the questions on the origin and dissemination of HLB-associated ‘Ca. L. asiaticus. Methods Sample collection/DNA extraction DNA from HLB-affected samples from Asia (India, China,

Cambodia, Vietnam, Thailand, Taiwan, and Japan), North America (Florida, USA) find more and South America (State of São Paulo, Brazil) were extracted from the respective sources and sent as microbially-sterile and non-infectious samples. HLB-associated Liberibacter-free DNA samples were used as negative controls. Basically, leaf samples were collected from citrus trees with blotchy mottle and blotchy mottle-like symptoms. Leaves were washed under running tap water and blotted dry with paper towels. The midribs were then excised from the leaf blade. Total genomic DNA was extracted from 4-5 midribs per sample. Pexidartinib order Samples were ground in liquid nitrogen and DNA was extracted using the CTAB method. Precipitated DNA was dissolved

in 100 μl of TE buffer. The quality of DNA samples was checked by electrophoresis in 1.2% agarose gels. DNA samples were diluted 30 times with water for PCR. Microsatellite marker development To identify putative microsatellite regions in the ‘Ca. L. asiaticus’ genome, we used the program ‘Tandem Repeats Finder’ [36]. Following the identification of these regions, primers were designed (Eurofins-Operon) that flanked the prospective repeat sequence to generate a FK228 concentration product of 150-400 base pairs. Over 100 primer sets were tested using multiple DNA samples obtained from HLB-affected plants from India, China, Brazil and Florida. We postulated that polymorphisms,

if present, should be observed within this pilot sample due to their geographic separation. Following amplification of regions containing putative microsatellite using the test primers, the products of each reaction were then run on 5% of polyacrylamide gels. Silver staining was then used to visualize polymorphic alleles. This screening procedure identified seven loci with amplified sequence length variability. To facilitate high-throughput genotyping analysis, each of seven forward primers was labelled with a fluorescent Idoxuridine dye (Table 1). Amplified products were analyzed by an ABI 3130 xl Genetic Analyser (Applied Biosystems, Foster City, CA). PCR based genotyping PCR was performed in 20 μl containing 2 μl of 10× reaction buffer, 1.5 mM MgCl2, 0.2 mM dNTPs, 0.25 U AmpliTaq Gold (Applied Biosystems, Foster City, CA), 2.5 pmole of each of SSR primer pairs and 2 μl of diluted DNA sample. PCR was conducted in the following conditions: 94°C for 4 minutes; 40 cycles consisting of 94°C for 45 seconds, annealing temperature (Table 1) for 45 seconds, and 72°C for 45 seconds; then a final extension at 72°C for 7 minutes. The successes of amplifications were checked running 5 μl of amplified products in agarose gel electrophoresis using 2.5% agarose-TBE gels.

In their study, MSH2 and MLH1 levels were normalized relative to

In their study, MSH2 and MLH1 levels were normalized relative to beta-tubulin levels and the level of MMR proteins in the heterozygous immortalized lymphocyte extracts was reported as percentage of the mean value of three controls. Their quantification of MMR protein levels was not determined as a ratio between MSH2 and MLH1 as we did in our study. While they claim that MLH1 protein levels were not decreased in MLH1+/- cells, their reported data for MLH1 levels show a wide range of variation. Their calculated mean MLH1 protein level for the 12

MLH1+/- lymphocyte find more cell lines was 86.8% of controls, but the range was 44% to 117% of controls with the standard deviation (SDE) being ± 19.1. Given that there was such a wide range, it seems as though MLH1 levels are actually reduced in several of their immortalized lymphocyte lines that are heterozygous for MLH1 mutations. Although our immunoassay is based Apoptosis inhibitor on protein expression, it should have several advantages over assays based on genetic tests. Genetic tests such as DNA sequencing and microsatellite analysis are accurate, but are more expensive, take longer to do, and are mainly available at commercial

laboratories. Also, DNA sequencing and microsatellite analysis is often done on patients who already have cancer and have a positive history of cancer. For these reasons, using genetic tests is not a practical way to screen large populations. In contrast, an immunoassay such as ours could be advanced to an automated diagnostic platform that is inexpensive, rapid and widely available. Moreover, since an immunoassay does not detect a genetic alteration, testing should not require a signed informed consent,

which would be required for patients undergoing genetic testing. Indeed, in testing tumor tissues from patients who have already developed colon cancer for LS, an immunoassay (i.e., immunohistochemistry) is often used as a pre-screen Carnitine dehydrogenase before gene sequencing. In this case, Navitoclax chemical structure immunohistochemistry is considered to be more feasible than the more complex strategy of genotyping for MSI [13]. Moreover, immunohistochemistry on tumor tissue is widely available, cost effective, and widely done without informed consent. This illustrates that clinicians are quite familiar with the use of immunoassays to diagnose human diseases. Also, we are currently in the process of advancing our immunoassay to a sandwich ELISA format, which should have enhanced sensitivity, and would be a step closer to a commercially available clinical assay. Finally, this study bears repeating as a prospective study in which genotyping is done, which was beyond the scope of our current pilot study. Acknowledgements This study was supported by grants from NIH (R44 CA 090122) and The Delaware Economic Development Office. Samar Hassen is grateful to the Graduate Institute of Technology, University of Arkansas at Little Rock for a research assistantship. References 1. Jemal A, Siegel R, Xu J, Ward E: Cancer Statistics.

Comparisons

Comparisons EPZ015666 were also made, as shown in Figure 7, with those related studies for the SB525334 in vitro viscosities of 40 and 80 cP. The present data are consistently higher than those of previous studies [2, 10] with regard to both the percentage of

the stretched DNA molecules and their stretch ratio. In fact, about 10% of DNA molecule stretch can reach the ratio of 0.52, and about 7% of DNA molecules can reach 0.63. Again, these are higher levels than those of previous studies. Table 4 shows a summary of the DNA mean stretching rate for all the cases under study. Figure 6 Stretching ratio histogram for different buffers with different viscosities. (a) 40 cP, (b) 60 cP, and (c) 80 cP. Figure 7 Comparisons with the related previous studies for DNA stretching. Table 4 DNA mean stretching rate Input voltage (DC) Buffer viscosity (cP) 1× TE 1× TAE 1× TBE 1× TPE 1× TBS 2.6 V 40 0.26 0.252 0.253 0.265 0.262 60 0.271 0.266 0.271 0.2676 0.2754 80 0.278 0.283 0.281 0.28 0.2844 2.8 V 40 0.284 0.2867 0.283 0.2867 0.2922 60 0.288 0.293 0.289 0.2917 0.2953 80 0.311 0.301 0.3 NVP-HSP990 solubility dmso 0.3035 0.308 3.0 V 40 0.302 0.309 0.302 0.3031 0.3061 60 0.317 0.315 0.307 0.316 0.315 80 0.318 0.317 0.318 0.3165 0.317 Based on the DNA molecule conformation history, it was found that the entire semi-annular duct exhibited two different opposite trends. First, in the first half duct (i.e., θ ≤ 90°), the DNA molecules obviously experienced stretching; however, for the second

half duct (i.e., 90° < θ ≤ 180°), it experienced an opposite behavior like recoiling. This

is also evidenced by Figure 8, as time increases with an interval of Δt = 5 s. Figure 9a,b shows the relaxation time versus viscosity and the functional relationship of viscosity with , respectively. Following Figure 9a, one may conclude that the relaxation time was a function of as well. Also included in Figure 9a are those from the Rouse/Zimm model and Fang et al. [11] for comparison. Good agreement and consistency were found. In fact, the present results for the five different buffers under study were between those of existing models. In Figure 9b, the viscosity which was correlated in terms of power law with an average power of 0.7 was found under different DC voltage inputs. The maximum stretch of the stretching force was plotted and Idoxuridine is shown in Figure 9a with comparisons to those of listed models [12, 13]. The data shown strongly indicated that a small stretching force was needed, as compared to the existing model with the same stretching length. However, the developing trend of the present study is the same as those of existing models [12]. The viscosity effect for μ = 40 ~ 80 cP of the present study seems not to have been noted as far as the stretching force is concerned, as shown in Figure 10.

Conclusions In the present study, we propose and validate by opti

Conclusions In the present study, we propose and validate by optical measurements a new method to achieve the in situ synthesis of tailored oligonucleotide sequences on porous silicon supports suitable for label-free optical biosensing. In particular, we demonstrate that,

differently from aqueous ammonia, the use of dry ammonia in methanol allows the effective deprotection of nucleobases without harming the structural integrity of the porous silicon matrix, thus opening the way for the direct growing of mixed-sequence ONs on optically active PSi supports using exclusively inexpensive standard phosphoramidites. A 19-mer FK228 in vivo mixed-sequence 5′-GATTGATGTGGTTGATTTT-3′ has been synthesized in mesoporous PSi microcavities, resulting in a medium-yield process, mainly due to the average pore size (about 20 nm). PSi photonic devices with pore dimensions greater than that value, but always compatible with high optical quality response in the visible-near-infrared, therefore between 50 and 100 nm, will be considered in the next experiments,

in order to maximize yield synthesis. Moreover, more stable PSi supports could also be considered, such as those produced by thermal acetylation, which maintains pore size and makes it very stable from the chemical point of view [18]. Acknowledgements This work has been partially supported by the national project PON Oncology. References 1. Heller MJ: DNA microarray technology: devices, this website systems, and applications. Annu Rev Biomed Eng 2002, 4:129–153. 10.1146/annurev.bioeng.4.020702.15343812117754CrossRef 2. Wang J, Rivas G, Cai X, Palecek M, Nielsen P, Shiraishi H, Dontha N, Luo D, Parrado C, Chicharro M, Flair MN: DNA electrochemical Cediranib (AZD2171) biosensors for environmental

monitoring. A review. Anal Chim Acta 1997, 347:1–8. 10.1016/S0003-2670(96)00598-3CrossRef 3. Leonard P, Hearty S, Joanne B, Lynsey D, Chakraborty T, O’Kennedy R: Advances in biosensors for detection of pathogens in food and water. Enzym Microb Technol 2003, 32:3–13. 10.1016/S0141-0229(02)00232-6CrossRef 4. Lehman V: Electrochemistry of Silicon. New York: Wiley; 2002.CrossRef 5. Leigh C: Properties of Porous Silicon. London: INSPEC/IEE; 1997. 6. Bisi O, Ossicini S, AZD3965 ic50 Pavesi L: Porous silicon: a quantum sponge structure for silicon based optoelectronics. Surf Sci Rep 2000, 38:1–126. 10.1016/S0167-5729(99)00012-6CrossRef 7. Pavesi L: Porous silicon dielectric multilayers and microcavities. La Rivista del Nuovo Cimento 1997, 20:1–76.CrossRef 8. De Tommasi E, Rendina I, Rea I, Di Sarno V, Rotiroti L, Arcari P, Lamberti A, Sanges C, De Stefano L: Porous silicon based resonant mirrors for biochemical sensing. Sensors 2008, 8:6549–6556. 10.3390/s8106549CrossRef 9. De Stefano L, Rea I, Giardina I, Armenante A, Rendina I: Protein modified porous silicon nanostructures. Adv Mat 2008, 20:1529–1533. 10.1002/adma.200702454CrossRef 10.

Mol Microbiol 1999,31(3):893–902 PubMedCrossRef 9 Outten FW, Out

Mol Microbiol 1999,31(3):893–902.PubMedCrossRef 9. Outten FW, Outten CE, Hale J, www.selleckchem.com/products/pf299804.html O’Halloran TV: Transcriptional activation of an Crenigacestat research buy Escherichia coli copper efflux regulon by the chromosomal MerR homologue, cueR. J Biol Chem 2000,275(40):31024–31029.PubMedCrossRef 10. Blindauer CA, Harrison MD, Parkinson JA, Robinson AK, Cavet JS, Robinson NJ, Sadler PJ: A metallothionein containing a zinc finger within a four-metal cluster protects a bacterium from zinc toxicity. Proc Natl Acad Sci U S A 2001,98(17):9593–9598.PubMedCentralPubMedCrossRef 11. Pulliainen AT, Kauko A, Haataja S, Papageorgiou AC, Finne J: Dps/Dpr ferritin-like protein: insights into the

mechanism of iron incorporation and evidence for a central

role in cellular iron homeostasis in Streptococcus suis . Mol Microbiol 2005,57(4):1086–1100.PubMedCrossRef 12. Hantke K: Bacterial zinc uptake and regulators. Curr Opin Microbiol 2005,8(2):196–202.PubMedCrossRef Selleck Dibutyryl-cAMP 13. Moore CM, Helmann JD: Metal ion homeostasis in Bacillus subtilis . Curr Opin Microbiol 2005,8(2):188–195.PubMedCrossRef 14. Carpenter BM, Whitmire JM, Merrell DS: This is not your mother’s repressor: the complex role of fur in pathogenesis. Infect Immun 2009,77(7):2590–2601.PubMedCentralPubMedCrossRef 15. Horsburgh MJ, Ingham E, Foster SJ: In Staphylococcus aureus , Fur is an interactive regulator with PerR, contributes to virulence, and Is necessary for oxidative stress resistance through positive regulation of catalase and iron homeostasis. J Bacteriol 2001,183(2):468–475.PubMedCentralPubMedCrossRef 16. Wösten MM, Kox LF, Chamnongpol S, Soncini FC, Groisman EA: A signal transduction

system that responds to extracellular iron. Cell 2000,103(1):113–125.PubMedCrossRef 17. Gunn JS: The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more. Trends Microbiol 2008,16(6):284–290.PubMedCrossRef 18. Nishino K, Hsu FF, Turk J, Cromie MJ, Wosten MM, Groisman EA: Identification of the lipopolysaccharide modifications controlled by the Salmonella PmrA/PmrB system mediating resistance to Fe(III) and Al(III). Mol Microbiol 2006,61(3):645–654.PubMedCentralPubMedCrossRef 19. Kato A, Chen HD, Latifi T, Groisman Acetophenone EA: Reciprocal control between a bacterium’s regulatory system and the modification status of its lipopolysaccharide. Mol Cell 2012,47(6):897–908.PubMedCentralPubMedCrossRef 20. Ogasawara H, Shinohara S, Yamamoto K, Ishihama A: Novel regulation targets of the metal-response BasS-BasR two-component system of Escherichia coli . Microbiology 2012,158(Pt 6):1482–1492.PubMedCrossRef 21. Leonhartsberger S, Huber A, Lottspeich F, Bock A: The hydH/G Genes from Escherichia coli code for a zinc and lead responsive two-component regulatory system. J Mol Biol 2001,307(1):93–105.PubMedCrossRef 22.

Furthermore, the soft tissues surrounding the scapula were widely

Furthermore, the soft tissues surrounding the scapula were widely invaded. The surgical classification system and systemic adjuvant therapy both assist in defining safe resection borders and guiding muscle reconstruction. Type A resections (abductors preserved) and Type I-III resections of the shoulder girdle always

entail an intracompartmental resection [14]. Accordingly, Omipalisib cell line partial scapulectomy (Type IIA) and scapular allograft reconstructions were performed successfully in all seven patients described herein. Chondrosarcomas are primarily located in region S1 (55%) and secondarily in region S2 (23%). Chondrosarcomas in region S1 are treated with partial scapulectomy whereas a total scapulectomy is performed more frequently in patients with a chondrosarcoma larger than 5 cm or for those located in region S2 [16]. This finding

is not consistent with the two patients in this series diagnosed with chondrosarcomas (#1 and 2). Instead of a total scapulectomy, a partial scapulectomy was elected for both patients because of the low stage of chondrosarcoma, despite the fact that both tumors were larger than 5 cm and located Compound C in vitro in region S2. The tumors of the remaining five patients were primarily detected in region S2. The scapular resection for lower stage tumors in these five patients indicated a Type IIA procedure. Among those tumors, chondroblastoma of the scapula is considered an DOK2 aggressive but benign tumor associated with local recurrence and pulmonary metastasis [17]. Since patient #6 presented with the same features and potential damage as a malignant scapular tumor, we elected to treat this patient with wide resection. In general,

an adequate surgical Selleckchem CRT0066101 margin was achieved based on a favorable histological type and surgical stage along with the requisite adjuvant therapy. Therefore, a wide marginal resection that permits the secure reattachment of the important soft tissues of the shoulder should be a therapeutic goal in these patients. Most rotator cuffs, external rotators, and muscles around the thoracoscapula were sacrificed to obtain a safe surgical margin. Nonetheless, we paid particular attention to restoration of essential shoulder abduction, flexion and stability in order to meet out patient’ post-operative needs. It should be noted that the relatively intact deltoid and articular capsule are requisite for achieving the desired level of motion and stability. The initial incision was considered a key factor in obtaining an adequate surgical margin and optimal reconstruction. The incision site and subsequent course was determined with several important goals in mind. One was to expose the bony and muscular elements of the region while providing adequate exposure for allograft reconstruction. Another was to minimize the loss of the uninvolved soft tissue (an opinion which is consistent with other experts in this field [18]).

J Biol Chem 279:22866–22874PubMedCrossRef Logan BA, Baker DH, Ada

J Biol Chem 279:22866–22874PubMedCrossRef Logan BA, Baker DH, Adams WWIII, Demmig-Adams B (1997) The response of xanthophyll cycle-dependent energy dissipation in Alocasia brisbanensis to sunflecks in a LY2606368 in vitro subtropical rainforest. Aust buy I-BET151 J Plant Physiol 24:27–33CrossRef Matsubara S, Krause GH, Aranda

J, Virgo A, Beisel KG, Jahns P, Winter K (2009) Sun-shade patterns of leaf carotenoid composition in 86 species of neotropical forest plants. Funct Plant Biol 36:20–36CrossRef Nagel KA, Schurr U, Walter A (2006) Dynamics of root growth stimulation in Nicotiana tabacum in increasing light intensity. Plant Cell Environ 29:1936–1945PubMedCrossRef Niyogi KK, Grossman AR, Björkman O (1998) Arabidopsis mutants define a central role for the xanthophyll cycle in the regulation of photosynthetic energy conversion.

Plant Cell 10:1121–1134PubMed Ögren E, Sundin U (1996) Photosynthetic responses to variable light: a comparison of species from contrasting habitats. Oecologia 106:18–27 Osmond CB, Grace SC (1995) Perspectives on photoinhibition and photorespiration in the field: quintessential inefficiencies of the light and dark reactions of photosynthesis? J Exp Bot 46:1351–1362 Pearcy RW (1990) Sunflecks and photosynthesis in plant canopies. Annu Rev Plant Physiol Plant Mol Biol 41:421–453CrossRef Pearcy RW, Calkin H (1983) Carbon dioxide exchange of C3 and C4 tree species in the understory of a Hawaiian forest. Oecologia 58:26–32CrossRef Pfannschmidt T (2003) Chloroplast redox signals: how photosynthesis controls its own genes. Trends Plant Sci 8:33–41PubMedCrossRef

Pons TL, Pearcy RW, Seemann see more JR (1992) Photosynthesis in flashing light in soybean leaves grown in different conditions. I. Photosynthetic induction state and regulation of ribulose-1,5-bisphosphate carboxylase activity. Plant Cell Environ 15:569–576CrossRef Schreiber U (2004) Pulse-amplitude-modulation (PAM) fluorometry and saturation pulse method: an overview. In: Papageorgiou GC, Govindjee (eds) Chlorophyll a fluorescence: a signature of photosynthesis. Springer, Dordrecht, pp 279–319 Sims DA, Pearcy RW (1993) Sunfleck frequency and duration affect growth-rate of the understorey plant, Alocasia macrorrhiza. Funct Ecol 7:683–689CrossRef Walter A, Scharr selleck chemicals llc H, Gilmer F, Zierer R, Nagel KA, Ernst M, Wiese A, Virnich O, Christ MM, Uhlig B, Jünger S, Schurr U (2007) Dynamics of seedling growth acclimation towards altered light conditions can be quantified via GROWSCREEN: a setup and procedure designed for rapid optical phenotyping of different plant species. New Phytol 174:447–455PubMedCrossRef Walters RG (2005) Towards an understanding of photosynthetic acclimation. J Exp Bot 56:435–447PubMedCrossRef Watling JR, Ball MC, Woodrow IE (1997a) The utilization of lightflecks for growth in four Australian rain-forest species.

Science 1995, 269:1550–1553

Science 1995, 269:1550–1553.CrossRef 2. Baughman RH, Zakhidov AA, Heer WA: Carbon nanotubes-the route toward applications. Science 2002, 297:787–792.CrossRef 3. Kong J, Franklin NR, Zhou C, Chapline MG, Peng S, Cho K, Dai H: Nanotube molecular wires as chemical sensors. Science 2000, 287:622–625.CrossRef 4. Collins PG, Captisol in vitro Bradly K, Ishigami Selleck Nepicastat M, Zettl A: Extreme oxygen sensitivity of electronic properties of carbon nanotubes. Science 2000, 287:1801–1804.CrossRef 5. Li J, Lu Y, Ye Q, Cinke M, Han J, Meyyappan M: Carbon nanotube sensors for gas and organic vapor detection. Nano Lett 2003, 3:929–933.CrossRef 6. Mitsui T, Shingehara T: Application

of metal-insulator-metal thin films as cold cathodes to the Bayard-Alpert gauge. Vacuum 1990, 41:1802–1804.CrossRef 7. Getty SA, King TT, Bis RA, Jones HH, Herrero F, Lynch BA, Roman P, Mahaffy P: Performance of a carbon nanotube field emission

electron gun. Proc SPIE 2007, 6556:655618.CrossRef 8. Getty SA, Bis RA, Snyder S, Gehreis E, Ramirez K, King TT, Roman A, Mahaffy PR: Effect of nitrogen gas on the lifetime of carbon nanotube field emitters for electron-impact Selleckchem JPH203 ionization mass spectrometry. Proc SPIE 2008, 6959:695907.CrossRef 9. Getty SA, Li M, Hess L, Costen N, King TT, Roman PA, Brinckerhoff WB, Mahaffy PR: Integration of a carbon nanotube field emission electron gun for a miniaturized time-of-flight mass spectrometer. Proc SPIE 2009, 7318:731816.CrossRef 10. Ogiwara N, Suganuma K, Miyo Y, Kobayashi S, Saito Y: Application of the field emitter array to the vacuum measurements. Appl Surf Sci 1999, 146:234–238.CrossRef 11. Dong C, Myneni GR: Carbon nanotube electron source based ionization vacuum gauge. Appl Phys Lett 2004, 84:5443–5445.CrossRef 12. Watanabe F, Suemitsu M: Separation of electron-stimulated-desorption

neutrals from outgassing originating from the grid surface of emission-controlled gauges: Studies with a heated-grid gauge. J Vac Sci Technol A 1999, Metalloexopeptidase 17:3467–3472.CrossRef 13. Tyler T, Shenderova OA, McGuire GE: Vacuum microelectronic devices and vacuum requirements. J Vac Sci Technol A 2005, 23:1260–1266.CrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions The work presented here was carried out in collaboration among all authors. KYD, JC, and BKJ defined the research theme. KYD, JC, and YDL designed the methods and experiments, carried out the laboratory experiments, analyzed the data, interpreted the results, and wrote the paper. BHK and YDL worked on the associated data collection and their interpretation and wrote the paper. KYD, JC, and BKJ designed the experiments, discussed the analyses, and wrote the paper. All authors read and approved the final manuscript.”
“Background The Hartman [1] effect is known as the independence of the tunneling time on the barrier width as this parameter gets large.